Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astria Therapeutics, Inc. - Common Stock
(NQ:
ATXS
)
12.58
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Astria Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 11, 2023
Via
Benzinga
Astria Therapeutics: Q1 Earnings Insights
↗
May 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
↗
March 28, 2023
Via
Benzinga
Earnings Outlook For Astria Therapeutics
↗
March 21, 2023
Via
Benzinga
MillerKnoll, Cleveland-Cliffs And Some Other Big Stocks Moving Higher On Thursday
↗
December 22, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 400 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
$10 Million Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
↗
December 22, 2022
Although US stocks closed sharply higher on Wednesday, there were a few notable insider trades.
Via
Benzinga
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
↗
December 19, 2022
Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on...
Via
Benzinga
Dow Dips Over 800 Points; S&P 500 Down 2.8%
↗
December 15, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 800 points.
Via
Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
↗
December 15, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
RCI Hospitality, AbCellera Biologics And Some Other Big Stocks Moving Higher On Thursday
↗
December 15, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 600 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Astria Therapeutics' Potential Hereditary Angioedema Candidate Shows Encouraging Action In Healthy Participants
↗
December 15, 2022
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
↗
August 04, 2022
The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients...
Via
Benzinga
Astria Therapeutics Commences Initial-Stage Skin Disorder Study, Sees Preliminary Data By Year-end
↗
August 04, 2022
Astria Therapeutics (NASDAQ: ATXS) announced initiation of a Phase 1a clinical trial of STAR-0215 in healthy subjects. STAR-0215 is designed to provide long-acting, effective attack prevention for...
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End of The Day Summary
↗
July 28, 2022
Via
Benzinga
Astria Therapeutics Gets FDA Nod For Initial-Stage Hereditary Angioedema Study
↗
July 28, 2022
The U.S. Food and Drug Administration (FDA) announced clearance to Astria Therapeutics’ (NASDAQ: ATXS) Investigational New Drug (IND) application for STAR-0215 in the treatment of Hereditary Angioedema...
Via
Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
↗
July 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 08, 2022
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 01, 2022
Via
Benzinga
62 Biggest Movers From Yesterday
↗
June 02, 2022
Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.
Via
Benzinga
(ATXS) - Analyzing Astria Therapeutics Inc. - Common Stock's Short Interest
↗
March 21, 2022
Astria Therapeutics Inc. - Common Stock's (NASDAQ:ATXS) short percent of float has fallen 18.83% since its last report. The company recently reported that it has 150.40 thousand...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 04, 2022
Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...
Via
Benzinga
50 Biggest Movers From Friday
↗
February 07, 2022
Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2021
↗
September 29, 2021
Upgrades For Spirit AeroSystems Holdings Inc (NYSE:
Via
Benzinga
64 Biggest Movers From Yesterday
↗
February 01, 2022
Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...
Via
Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
↗
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.